Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Management of Intra-abdominal Infection

Publication Date: July 11, 2024

Last Updated: July 17, 2024

Aminoglycosides

We recommend against aminoglycoside-based combination regimens for empiric therapy of higher risk patients. ( 1 , A )

687

Beta-lactamase inhibitor combinations

We recommend cefoperazone-sulbactam for empiric therapy of lower risk patients. ( 1 , B )

Management of Intra-abdominal Infection

Aminoglycosides

Beta-lactamase inhibitor combinations

Overview

Title

Authoring Organization